← Back to Search

Maternal Scent Group for Infant Development

N/A
Waitlist Available
Led By Rakesh Sahni, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infants born at 30 weeks gestation to 36 weeks gestation.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hours
Awards & highlights

Study Summary

This trial will study whether exposing premature infants to their mother's scent helps them develop better than without the exposure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of time spent active sleep
Percentage of time spent in quiet sleep
Secondary outcome measures
Beta to theta ratio
Number of mothers diagnosed with acute stress disorder based on score on the Stanford Acute Stress Reaction Questionnaire (SASRQ)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Maternal Scent GroupExperimental Treatment1 Intervention
Infants in this group will be exposed to a breast pad worn by their mothers to extract maternal scent. This exposure will last 24 hours.
Group II: Control GroupActive Control1 Intervention
Infants in this group will receive standard of care.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,181 Total Patients Enrolled
2 Trials studying Infant Development
4,523 Patients Enrolled for Infant Development
Rakesh Sahni, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025